2013 - CTS 2013 Congress


This page contains exclusive content for the member of the following sections: TTS, CTS. Log in to view.

Oral Communications 7

15.1 - The Ex-Vivo Assembly and Transplantation of a LGR6+ Epithelial Stem Cell-Derived Hybrid Graft Using Common Acellular Matrices To Augment Wound Healing and Nascent Hair Growth in Tissues Devoid of Adnexal Structures

Presenter: Denver, Lough, Springfield, United States
Authors: Denver Lough1,2, Damon Cooney1,2, Shaun Mendenhall1,2, Mei Yang1,2, Joel Reichensperger1,2, Lisa Cox1,2, Nicole Cosenza1,2, Nathan Wetter1,2, Carrie Harrison1,2, Michael Neumeister1,2

The Ex-Vivo Assembly and Transplantation of a LGR6+ Epithelial Stem Cell-Derived Hybrid Graft Using Common Acellular Matrices To Augment Wound Healing and Nascent Hair Growth in Tissues Devoid of Adnexal Structures

Denver Lough1,2, Damon Cooney1,2, Shaun Mendenhall1,2, Mei Yang1,2, Joel Reichensperger1,2, Lisa Cox1,2, Nicole Cosenza1,2, Nathan Wetter1,2, Carrie Harrison1,2, Michael Neumeister1,2

1Surgery/Plastic Surgery, SIU School of Medicine, Springfield, IL, United States; 2Plastic and Reconstructive Surgery, The Johns Hopkins Hospital, Baltimore, MD, United States

Background: Previous research shows that the migration of the Leucine-rich repeat-containing G-protein coupled Receptor epithelial stem cell (LGR5+ and LGR6+ ESC) into wounds augments healing and permits nascent hair growth in areas devoid of these cells following local full thickness soft tissue trauma. Here, we assess the LGR-expressing cell’s potential as a hybrid graft in full thickness soft tissue wounds with the goal of developing an easily assembled biological dressing to provide patients with their own focal epithelial stem cell population, capable of growing functional, hair producing skin.

Methods: GFP expressing LGR6+ ESCs were isolated from C57BL/6(UBC-GFP) mice using FACS gated on CD34, CD73, and LGR6. These cells were then seeded on a variety of acellular matrices. Viability and attachment was assessed using confocal, scanning electron microscopy and bioluminescence. LRG6+ ESC seeded matrices were placed into acute 3rd degree burn wound beds of Nu/Nu mice and monitored for viability, wound healing, and growth factor expression. Bioluminescent imaging supported LGR6+ ESC confluence within the graft as well as transplant viability. Healing rates were documented and compared between mice receiving the LGR6+ ESC enriched grafts vs. control. On days 0, 5, 10 and 15, grafted areas were harvested and assessed for gross, microscopic and molecular healing using digital imaging, immunofluorescence, RT-PCR, and angiogenic proteome array analysis.

Results: LGR6+ seeded matrices show significantly enhanced gross wound healing and up regulation of key WNT, EGF, VEGF and angiogenesis mRNA transcripts and peptides, when compared to matrix-only and negative controls. Additionally, those full thickness wound beds receiving the LGR6+ ESC hybrid grafts were capable of growing nascent hair from the wound bed within a Nu/Nu murine model.

Conclusion: Here, we suggest a novel role for an LGR6+ ESC-enriched hybrid graft for the development of a fully transplantable living matrix for use in tissue engineering and reconstructive transplantation. Furthermore, with the epithelium being a major source of alloantigenicity, this system can be used to develop a series of chimeric epithelial expansion foci for engraftment within more complex composite tissue allografts in order to promote tolerance.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada